Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

The CD36 rs1761667 Variant, the Adipotide Pathway, and Weight Management: What Your Genotype May Mean

Adipose tissue is an active part of energy balance, storing fat when energy is abundant and releasing it when needed. Research on Adipotide has explored how changing the blood supply to fat tissue may affect fat cell biology and metabolism. The CD36 gene helps move long-chain fatty acids into cells, including in fat, muscle, and liver, where they can be used for energy or stored. Differences in CD36 activity may influence how efficiently the body handles fats and supports metabolic health.

Genetic variation in the CD36 gene may influence how efficiently the biological processes connected to Adipotide and Weight Management function. The rs1761667 variant is analyzed in the PlexusDx Precision Peptide Genetic Test as part of the Weight Management pathway. Depending on your genotype, this variant may have a modest to meaningful influence on adipokine signaling, insulin sensitivity, and metabolic regulation. Understanding your result gives you a personalized starting point for targeted lifestyle, dietary, and supplement strategies grounded in your unique biology.

Practical Foundations for Everyone

Regardless of your CD36 rs1761667 genotype, the following lifestyle inputs consistently support body composition, metabolic balance, and fat metabolism efficiency. Carriers of the effect allele often notice a stronger return on these habits when applied consistently — which makes regularity more valuable than intensity.

  • Consistent nutrition: A whole-food dietary pattern rich in vegetables, quality protein, healthy fats, and fiber provides the micronutrient foundation that supports weight management-related pathways at a cellular level.
  • Regular movement: Physical activity — particularly a combination of aerobic exercise and resistance training — supports the metabolic signaling and growth factor pathways that interact with weight management and biological resilience.
  • Quality sleep: Restorative sleep is essential for cellular repair, hormone regulation, and the metabolic processes that underpin weight management. Consistent sleep timing amplifies the benefits of other lifestyle habits.
  • Stress management: Chronic stress elevates cortisol and inflammatory markers that can blunt the efficiency of pathways related to weight management. A daily stress-reduction practice — even five to ten minutes of slow breathing or mindfulness — helps maintain biological balance.

Diet Recommendations for CD36 rs1761667 and the Adipotide Pathway

A targeted nutritional approach for the CD36 rs1761667 variant focuses on supplying the micronutrients and macronutrient balance that support adipokine signaling, insulin sensitivity, and metabolic regulation and reduce the metabolic burden on pathways connected to Adipotide. Priority nutrients vary by pathway but consistently center on anti-inflammatory whole foods, adequate protein for cellular and tissue support, and micronutrient density from colorful produce and quality fats.

The GLP-1 Support is designed to support this pathway. A nutrient-dense plan supporting GLP-1 medications with protein, healthy fats, and fiber to enhance results and minimize side effects....

Build meals around quality protein sources (fish, poultry, legumes, eggs), fiber-rich carbohydrates (vegetables, whole grains, legumes), and healthy fats (olive oil, avocado, nuts, seeds). Minimize ultra-processed foods, excessive added sugars, and alcohol — all of which increase oxidative and inflammatory burden on pathways that interact with weight management and Adipotide-related signaling.

Supplement Considerations for CD36 rs1761667 Support

Supplements cannot modify your CD36 rs1761667 genotype, but targeted supplementation can address nutritional gaps and support the biological pathways connected to Adipotide and weight management. A foundations-first approach — prioritizing the basics before adding specialty products — produces the most consistent outcomes. Always discuss supplementation with your healthcare provider before starting, especially if you take medications or manage ongoing health conditions.

The PlexusDx Weight Loss Support is a personalized daily pack designed to support this pathway. PlexusDx Weight Loss Support Personalized Daily Pack combines berberine, green tea extract, and Forslean to help support healthy metabolism and promote effective weight management. Convenient pre-portioned packs make it easy to stay consistent while supporting energy, fat metabol...

Key nutrients commonly relevant to the Weight Management pathway include those that support adipokine signaling, insulin sensitivity, and metabolic regulation. Assess dietary gaps first; targeted supplementation is most valuable when it addresses a specific nutritional shortfall confirmed by food tracking or lab results rather than used as a substitute for consistent lifestyle habits.

Lifestyle Recommendations for Weight Management and Adipotide Pathway Support

Consistent lifestyle habits are the most durable and evidence-supported way to reinforce the biological pathways associated with Adipotide and weight management. For carriers of the CD36 rs1761667 effect allele, these habits tend to produce a more noticeable return because they directly influence the signaling environments where the variant has its greatest impact.

A practical weekly target is 150 minutes or more of moderate aerobic activity combined with two to three resistance training sessions. Sleep consistency — a fixed wake time, morning outdoor light, and a 60 to 90 minute wind-down before bed — supports cellular recovery and the hormonal balance that underpins weight management. Stress management practices such as slow breathing, mindfulness, or low-stimulation outdoor time help maintain the biological stability that Adipotide-related pathways depend on for efficient function. Avoiding chronic sleep debt, late-day caffeine, and excessive alcohol further removes common suppressors of weight management-related signaling.

Genetic Interpretations for rs1761667 (CD36)

2 Effect Alleles: AA (+/+)

You have the AA genotype for rs1761667 which means you carry two copies of the effect allele. This variation is associated with lower CD36 expression and reduced fatty-acid sensing/transport efficiency in many studies, which may influence how the body handles dietary fats and regulates adipose-tissue metabolism. In the context of the Adipotide pathway, this is relevant because Adipotide-related biology centers on adipose tissue function, vascular support, and the metabolic environment surrounding fat cells, while CD36 helps regulate how long-chain fatty acids are taken up into adipose tissue and other metabolically active tissues. Research on rs1761667 suggests the A allele is linked to reduced CD36 protein expression, altered fat taste perception, and in some studies higher fat preference or differences in BMI and lipid-related traits, indicating that one part of the fat-handling network may function less efficiently. For individuals with the AA genotype, this may suggest a somewhat less typical adipose-metabolic profile, with lifestyle factors playing a particularly important role in how energy balance is regulated. Helpful strategies may include emphasizing whole-food meals with adequate protein, fiber-rich carbohydrates, unsaturated fats in controlled portions, regular resistance and aerobic exercise, and minimizing frequent overeating of highly processed high-fat foods. Diets rich in polyphenol- and phytochemical-containing foods may also be especially supportive, since recent gene–diet interaction work suggests dietary pattern quality can influence metabolic risk markers in carriers of this variant. Overall, this genotype does not determine weight outcome on its own, but it may reflect a tendency toward less efficient fatty-acid handling within adipose-related metabolic pathways relevant to the broader Adipotide biology.

1 Effect Allele: AG (+/-)

You have the AG genotype for rs1761667, which means you carry one copy of the effect allele and one copy of the non-effect allele. This intermediate genotype may be associated with a moderate change in CD36-related fatty-acid transport and lipid sensing, often representing a middle-ground pattern between the two homozygous genotypes. In connection with the Adipotide pathway, this suggests that adipose tissue and other metabolically active tissues are likely to maintain broadly functional fatty-acid uptake and signaling, but with some potential for altered efficiency depending on the broader dietary and metabolic context. Because CD36 is involved not only in fatty-acid transport but also in fat taste perception and energy-homeostasis signaling, even modest variation may contribute to subtle differences in food preference, lipid metabolism, or body-composition response over time. Studies of rs1761667 most consistently support language around reduced CD36 expression with the A allele and possible effects on fat perception and metabolic traits, although the size of effect varies across populations. For this genotype, the practical focus is usually on keeping the metabolic environment favorable through balanced calorie intake, adequate protein, fiber, exercise with recovery, and attention to dietary quality rather than extreme restriction. A Mediterranean-style pattern rich in vegetables, legumes, olive oil, nuts, and other minimally processed foods may be especially helpful for supporting adipose and cardiometabolic health. Overall, this genotype is best viewed as a moderate-response marker within the broader fat-transport and adipose-metabolism network rather than a stand-alone predictor of weight-management outcomes.

0 Effect Alleles: GG (-/-)

You have the GG genotype for rs1761667 which means you carry two copies of the non-effect allele. This genotype is generally associated with typical CD36 expression and a more standard pattern of fatty-acid sensing and transport. In the context of the Adipotide pathway, this suggests that the CD36 portion of adipose-tissue metabolism is more likely to function within the expected range, helping support more typical long-chain fatty-acid uptake and lipid-handling signaling in adipose tissue and other metabolic organs. Since Adipotide-related biology involves adipose tissue function and the metabolic environment surrounding fat cells, this genotype suggests that CD36 is less likely to be a major limiting factor in that network. Even so, energy balance and weight regulation remain strongly influenced by many other variables including total calorie intake, protein adequacy, physical activity, sleep, insulin sensitivity, inflammation, and overall diet quality. The most useful recommendations for this genotype are therefore foundational: maintain a nutrient-dense eating pattern, adequate protein and fiber intake, regular exercise, restorative sleep, and consistent habits that support healthy body composition and lipid metabolism. Overall, this genotype is generally consistent with a more typical CD36-mediated contribution to adipose fatty-acid handling within the broader metabolic pathways relevant to Adipotide.

Inconclusive — No Result

Your genetic data for rs1761667, a CD36 gene variant, was not successfully called by the laboratory. This means the test did not detect a reliable result for this position, which can occur for technical reasons such as low signal intensity, DNA quality issues, or limitations of the genotyping array. Without a result, we cannot determine whether you carry the typical or effect variant for this gene. If this information is important for your health decisions, you may wish to consider retesting or confirming this variant through a targeted genetic test or sequencing method.

When to Talk to Your Healthcare Provider

If you have concerns related to weight management, the Adipotide pathway, or how your CD36 rs1761667 results fit into your broader health picture, consult your healthcare provider. They can interpret your genetic results alongside your symptoms, health history, and lab values to guide appropriate testing, dietary adjustments, and supplementation where relevant.

PlexusDx provides genetic insights to help you understand how your genes may influence nutrient needs and biological pathways. This information is provided for educational and wellness purposes only and does not diagnose, treat, or recommend any specific medication, peptide, or therapy, some of which may be prescription-only, investigational, or intended for research use only. Always consult with a qualified healthcare provider before making changes to your supplement regimen, diet, or health plan based on genetic information.

Frequently Asked Questions About CD36 rs1761667 and Adipotide

What does the CD36 rs1761667 variant mean for my weight management?

The rs1761667 variant in the CD36 gene may influence how efficiently biological processes connected to Adipotide and Weight Management function in your body. Depending on your genotype, this can have a modest to meaningful effect on adipokine signaling, insulin sensitivity, and metabolic regulation. Understanding your result gives you a personalized starting point for a targeted lifestyle and nutrition strategy grounded in your unique genetic biology.

How does the Adipotide pathway relate to CD36 and weight management?

Adipotide is a peptide being studied for its potential role in supporting body composition, metabolic balance, and fat metabolism efficiency. Researchers are interested in how Adipotide-associated pathways may interact with genes like CD36, which contribute to the signaling environments that influence weight management function. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150 genetic insights — including CD36 rs1761667 — to provide a comprehensive view of how your genetics may influence these interconnected systems.

Can lifestyle changes support CD36 function regardless of my genotype?

Yes. Consistent lifestyle habits — regular exercise, quality sleep, anti-inflammatory nutrition, and stress management — support weight management-related biological pathways across all genotypes. For carriers of the effect allele at rs1761667, these habits tend to produce a stronger measurable return because they directly reinforce the signaling environments where this variant has its greatest influence. Consistency and habit stacking — combining exercise, sleep, and nutrition improvements together — tends to produce better outcomes than any single change in isolation.

What tests can help me learn more about my weight management and the Adipotide pathway?

The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150 genetic insights — including CD36 rs1761667 — to deliver a comprehensive picture of how your genetics may influence peptide-related health pathways. The Peptide Pathways Report translates your results into personalized, actionable guidance. Your healthcare provider can also recommend targeted blood tests based on your specific pathway results and health history to complement your genetic insights with current biomarker data.

If this genetic variant is present in your PlexusDx results, the following tests and reports are commonly used to explore it further:

🧬 Genetic Tests:

📄 Genetic Report:

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.